Acute haemodynamic effects of IL-6 treatment in vivo

Involvement of vagus nerve in NO-mediated negative inotropism

Laura Comini, Evasio Pasini, Tiziana Bachetti, Michel Dreano, Gianni Garotta, Roberto Ferrari

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Interleukin-6 (IL-6) reduces myocardial haemodynamics. However, the intrinsic mechanisms of IL-6 effects are not known. We hypothesized that nitric oxide (NO) synthesised by neuronal synthase (nNOS) can be the molecular mediator of IL-6-mediated cardiac effects. Thus, we investigated in vivo after IL-6 acute administration: (1) the role of NO pathway; (2) the importance of NO derived from nNOS located in intracardiac vagal ganglion in the anterior surface of the left ventricle. Sprague-Dawley (SD) rats (225-250 g) were anaesthetized (sodium pentobarbital 30 mg/kg intraperitoneally administered) and ventilated. The effects of a single IL-6 bolus (100 μg/kg intravenously administered) were studied in four experimental groups: (a) IL-6 (n = 6), (b) IL-6 plus 30 mg/kg of l-NAME (an eNOS and nNOS inhibitor; n = 6), (c) IL-6 plus 25 mg/kg of 7-NI (a specific nNOS inhibitor; n = 6), (d) IL-6 plus vagal resection (n = 6). We evaluated the following parameters: mean aortic pressure (MAP), left ventricular end systolic pressure (LVESP), left ventricular positive peak dP/dt (PP dP/dt). Data are expressed as mean ± sem. IL-6 caused a transient but significant reduction of MAP (-21.8% of basal: p <0.05), LVESP (from 130 ± 4.2 to 1056.5 mmHg: p <0.05) and PP dP/dt (from 5390 ± 158 to 4400 ± 223 mmHg/s, p <0.02). Concomitant treatment with l-NAME or 7-NI totally abolished IL-6 effects. Vagal resection significantly reduced the haemodynamic effects (MAP: -10% of basal: p = ns; LVEDS: from 125 ± 7.3 to 117 ± 6.8 mmHg, p <0.05; PP dP/dt from 5500 ± 150 to 5000 ± 143 mmHg/s, p <0.05). We conclude that acute administration of IL-6 caused transient but significant cardiac negative inotropism. IL-6 haemodynamic effects are partly due to NO synthesised by nNOS located in vagal left ventricular ganglia.

Original languageEnglish
Pages (from-to)236-242
Number of pages7
JournalCytokine
Volume30
Issue number5
DOIs
Publication statusPublished - Jun 7 2005

Fingerprint

Vagus Nerve
Hemodynamics
Muscle Contraction
Interleukin-6
Nitric Oxide
Arterial Pressure
Ganglia
Blood Pressure
Myocardial Contraction
Nitric Oxide Synthase Type I
Pentobarbital
Heart Ventricles
Sprague Dawley Rats
Rats

Keywords

  • Haemodynamics
  • Interleukin-6
  • Nitric oxide
  • Vagus nerve

ASJC Scopus subject areas

  • Endocrinology
  • Molecular Biology
  • Immunology
  • Immunology and Allergy

Cite this

Acute haemodynamic effects of IL-6 treatment in vivo : Involvement of vagus nerve in NO-mediated negative inotropism. / Comini, Laura; Pasini, Evasio; Bachetti, Tiziana; Dreano, Michel; Garotta, Gianni; Ferrari, Roberto.

In: Cytokine, Vol. 30, No. 5, 07.06.2005, p. 236-242.

Research output: Contribution to journalArticle

@article{8b36f53cfe8b461e90b43610f478960a,
title = "Acute haemodynamic effects of IL-6 treatment in vivo: Involvement of vagus nerve in NO-mediated negative inotropism",
abstract = "Interleukin-6 (IL-6) reduces myocardial haemodynamics. However, the intrinsic mechanisms of IL-6 effects are not known. We hypothesized that nitric oxide (NO) synthesised by neuronal synthase (nNOS) can be the molecular mediator of IL-6-mediated cardiac effects. Thus, we investigated in vivo after IL-6 acute administration: (1) the role of NO pathway; (2) the importance of NO derived from nNOS located in intracardiac vagal ganglion in the anterior surface of the left ventricle. Sprague-Dawley (SD) rats (225-250 g) were anaesthetized (sodium pentobarbital 30 mg/kg intraperitoneally administered) and ventilated. The effects of a single IL-6 bolus (100 μg/kg intravenously administered) were studied in four experimental groups: (a) IL-6 (n = 6), (b) IL-6 plus 30 mg/kg of l-NAME (an eNOS and nNOS inhibitor; n = 6), (c) IL-6 plus 25 mg/kg of 7-NI (a specific nNOS inhibitor; n = 6), (d) IL-6 plus vagal resection (n = 6). We evaluated the following parameters: mean aortic pressure (MAP), left ventricular end systolic pressure (LVESP), left ventricular positive peak dP/dt (PP dP/dt). Data are expressed as mean ± sem. IL-6 caused a transient but significant reduction of MAP (-21.8{\%} of basal: p <0.05), LVESP (from 130 ± 4.2 to 1056.5 mmHg: p <0.05) and PP dP/dt (from 5390 ± 158 to 4400 ± 223 mmHg/s, p <0.02). Concomitant treatment with l-NAME or 7-NI totally abolished IL-6 effects. Vagal resection significantly reduced the haemodynamic effects (MAP: -10{\%} of basal: p = ns; LVEDS: from 125 ± 7.3 to 117 ± 6.8 mmHg, p <0.05; PP dP/dt from 5500 ± 150 to 5000 ± 143 mmHg/s, p <0.05). We conclude that acute administration of IL-6 caused transient but significant cardiac negative inotropism. IL-6 haemodynamic effects are partly due to NO synthesised by nNOS located in vagal left ventricular ganglia.",
keywords = "Haemodynamics, Interleukin-6, Nitric oxide, Vagus nerve",
author = "Laura Comini and Evasio Pasini and Tiziana Bachetti and Michel Dreano and Gianni Garotta and Roberto Ferrari",
year = "2005",
month = "6",
day = "7",
doi = "10.1016/j.cyto.2005.01.009",
language = "English",
volume = "30",
pages = "236--242",
journal = "Cytokine",
issn = "1043-4666",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Acute haemodynamic effects of IL-6 treatment in vivo

T2 - Involvement of vagus nerve in NO-mediated negative inotropism

AU - Comini, Laura

AU - Pasini, Evasio

AU - Bachetti, Tiziana

AU - Dreano, Michel

AU - Garotta, Gianni

AU - Ferrari, Roberto

PY - 2005/6/7

Y1 - 2005/6/7

N2 - Interleukin-6 (IL-6) reduces myocardial haemodynamics. However, the intrinsic mechanisms of IL-6 effects are not known. We hypothesized that nitric oxide (NO) synthesised by neuronal synthase (nNOS) can be the molecular mediator of IL-6-mediated cardiac effects. Thus, we investigated in vivo after IL-6 acute administration: (1) the role of NO pathway; (2) the importance of NO derived from nNOS located in intracardiac vagal ganglion in the anterior surface of the left ventricle. Sprague-Dawley (SD) rats (225-250 g) were anaesthetized (sodium pentobarbital 30 mg/kg intraperitoneally administered) and ventilated. The effects of a single IL-6 bolus (100 μg/kg intravenously administered) were studied in four experimental groups: (a) IL-6 (n = 6), (b) IL-6 plus 30 mg/kg of l-NAME (an eNOS and nNOS inhibitor; n = 6), (c) IL-6 plus 25 mg/kg of 7-NI (a specific nNOS inhibitor; n = 6), (d) IL-6 plus vagal resection (n = 6). We evaluated the following parameters: mean aortic pressure (MAP), left ventricular end systolic pressure (LVESP), left ventricular positive peak dP/dt (PP dP/dt). Data are expressed as mean ± sem. IL-6 caused a transient but significant reduction of MAP (-21.8% of basal: p <0.05), LVESP (from 130 ± 4.2 to 1056.5 mmHg: p <0.05) and PP dP/dt (from 5390 ± 158 to 4400 ± 223 mmHg/s, p <0.02). Concomitant treatment with l-NAME or 7-NI totally abolished IL-6 effects. Vagal resection significantly reduced the haemodynamic effects (MAP: -10% of basal: p = ns; LVEDS: from 125 ± 7.3 to 117 ± 6.8 mmHg, p <0.05; PP dP/dt from 5500 ± 150 to 5000 ± 143 mmHg/s, p <0.05). We conclude that acute administration of IL-6 caused transient but significant cardiac negative inotropism. IL-6 haemodynamic effects are partly due to NO synthesised by nNOS located in vagal left ventricular ganglia.

AB - Interleukin-6 (IL-6) reduces myocardial haemodynamics. However, the intrinsic mechanisms of IL-6 effects are not known. We hypothesized that nitric oxide (NO) synthesised by neuronal synthase (nNOS) can be the molecular mediator of IL-6-mediated cardiac effects. Thus, we investigated in vivo after IL-6 acute administration: (1) the role of NO pathway; (2) the importance of NO derived from nNOS located in intracardiac vagal ganglion in the anterior surface of the left ventricle. Sprague-Dawley (SD) rats (225-250 g) were anaesthetized (sodium pentobarbital 30 mg/kg intraperitoneally administered) and ventilated. The effects of a single IL-6 bolus (100 μg/kg intravenously administered) were studied in four experimental groups: (a) IL-6 (n = 6), (b) IL-6 plus 30 mg/kg of l-NAME (an eNOS and nNOS inhibitor; n = 6), (c) IL-6 plus 25 mg/kg of 7-NI (a specific nNOS inhibitor; n = 6), (d) IL-6 plus vagal resection (n = 6). We evaluated the following parameters: mean aortic pressure (MAP), left ventricular end systolic pressure (LVESP), left ventricular positive peak dP/dt (PP dP/dt). Data are expressed as mean ± sem. IL-6 caused a transient but significant reduction of MAP (-21.8% of basal: p <0.05), LVESP (from 130 ± 4.2 to 1056.5 mmHg: p <0.05) and PP dP/dt (from 5390 ± 158 to 4400 ± 223 mmHg/s, p <0.02). Concomitant treatment with l-NAME or 7-NI totally abolished IL-6 effects. Vagal resection significantly reduced the haemodynamic effects (MAP: -10% of basal: p = ns; LVEDS: from 125 ± 7.3 to 117 ± 6.8 mmHg, p <0.05; PP dP/dt from 5500 ± 150 to 5000 ± 143 mmHg/s, p <0.05). We conclude that acute administration of IL-6 caused transient but significant cardiac negative inotropism. IL-6 haemodynamic effects are partly due to NO synthesised by nNOS located in vagal left ventricular ganglia.

KW - Haemodynamics

KW - Interleukin-6

KW - Nitric oxide

KW - Vagus nerve

UR - http://www.scopus.com/inward/record.url?scp=20144363219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144363219&partnerID=8YFLogxK

U2 - 10.1016/j.cyto.2005.01.009

DO - 10.1016/j.cyto.2005.01.009

M3 - Article

VL - 30

SP - 236

EP - 242

JO - Cytokine

JF - Cytokine

SN - 1043-4666

IS - 5

ER -